CHEK will be looking for FDA approval by early 2023. US Pivotal Study will take place in 2022.
Support @ 1.47 / Resistance @ 2.26 B: 1.47 - 1.60 S: 2.26 - 2.93
Great time to enter chek at 2.1
#CHEK LONG from 1.75 to 4.60 Use stop loss!
Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening. Net Income $-13,840,000, but an encouraging Quick Ratio of 3.69. Looking at the volume, this asset can double its price is seconds. on 5/28/2020 HC Wainwright Reiterated Chek Rating to Buy and the target...
Entry. $0.69 S/L $0.60 TP $0.92 12 months Consensus Price Target: $3 if you find my charts useful, please leave me "like" or "comment". Please don't trade according to the ideas, rely on your own knowledge. Thx
NASDAQ: $CHEK looks ready to Continue Its Uptrend! #Breakout
Looks like we are about to enter into range trading for some time, or small pull back to 2.5. The idea here is that we are all waiting for some big announcement here. This is LONG investment, but seeing a double bottom here is encouraging. So it is just a matter of patience. Lots of patience. Good luck everyone ;) **LEGENDS** BLUE = Bear/Resistance Yellow...
Looking at a strong late afternoon run. Could something be brewing? RSI is trending up. Looks like the downward trend has signaled a bottom.